Balentine LLC Takes Position in UnitedHealth Group Inc (NYSE:UNH)

Balentine LLC purchased a new stake in shares of UnitedHealth Group Inc (NYSE:UNH) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 1,880 shares of the healthcare conglomerate’s stock, valued at approximately $469,000.

Other institutional investors also recently bought and sold shares of the company. RMR Wealth Builders bought a new stake in UnitedHealth Group in the fourth quarter worth $29,000. HBC Financial Services PLLC bought a new stake in UnitedHealth Group in the fourth quarter worth $30,000. Country Trust Bank boosted its holdings in UnitedHealth Group by 556.3% in the first quarter. Country Trust Bank now owns 105 shares of the healthcare conglomerate’s stock worth $26,000 after purchasing an additional 89 shares in the last quarter. Total Clarity Wealth Management Inc. bought a new stake in UnitedHealth Group in the fourth quarter worth $34,000. Finally, Beutel Goodman & Co Ltd. bought a new stake in UnitedHealth Group in the fourth quarter worth $36,000. Institutional investors and hedge funds own 86.59% of the company’s stock.

In other news, Director Stephen J. Hemsley sold 45,637 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $289.11, for a total transaction of $13,194,113.07. Following the sale, the director now directly owns 1,013,122 shares of the company’s stock, valued at approximately $292,903,701.42. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.80% of the stock is owned by insiders.

Shares of NYSE:UNH traded up $1.01 during trading on Friday, reaching $291.24. The stock had a trading volume of 5,172,840 shares, compared to its average volume of 4,047,542. The firm’s fifty day moving average is $293.73 and its 200 day moving average is $281.69. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.75 and a current ratio of 0.75. UnitedHealth Group Inc has a 52 week low of $187.72 and a 52 week high of $315.84. The stock has a market cap of $276.21 billion, a price-to-earnings ratio of 20.38, a P/E/G ratio of 1.43 and a beta of 0.72.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Wednesday, April 15th. The healthcare conglomerate reported $3.72 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.63 by $0.09. The company had revenue of $64.40 billion during the quarter, compared to analyst estimates of $64.25 billion. UnitedHealth Group had a net margin of 5.59% and a return on equity of 24.86%. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.73 earnings per share. On average, research analysts forecast that UnitedHealth Group Inc will post 16.24 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, June 22nd will be given a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.72%. The ex-dividend date of this dividend is Friday, June 19th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.08. UnitedHealth Group’s payout ratio is currently 28.59%.

A number of research firms have weighed in on UNH. Citigroup cut their target price on shares of UnitedHealth Group from $346.00 to $339.00 and set a “buy” rating for the company in a research report on Friday, April 24th. Raymond James cut their target price on shares of UnitedHealth Group from $340.00 to $325.00 in a research report on Thursday, April 16th. Deutsche Bank cut their price objective on shares of UnitedHealth Group from $308.00 to $293.00 and set a “buy” rating for the company in a research report on Thursday, April 16th. Morgan Stanley increased their target price on shares of UnitedHealth Group from $289.00 to $371.00 and gave the stock an “overweight” rating in a report on Thursday, April 30th. Finally, Stephens lifted their price objective on shares of UnitedHealth Group from $310.00 to $325.00 and gave the stock an “overweight” rating in a research note on Tuesday, June 2nd. Four research analysts have rated the stock with a hold rating and twenty-one have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $323.13.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: volatile stocks

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.